University of Illinois at Urbana-Champaign
This phase I clinical trial tests the feasibility and safety of a self-guided, mobile mindfulness-based intervention to reduce post-cesarean pain and prevent postpartum depression.
Postpartum pain affects approximately 92% of women and is a risk factor for postpartum depression (PPD). Cesarean delivery is associated with elevated risk for both postpartum pain and PPD, and women who experience persistent postpartum pain are at increased risk of developing depressive symptoms. PPD may contribute to withdrawal, emotional detachment, and hostility, which can negatively affect mother-infant interactions, including breastfeeding. These risks underscore the urgent need for an effective non-pharmacologic intervention to reduce post-cesarean delivery pain and prevent PPD. The obj…
1. Women must self-identify as Latina/Latinx/Hispanic, Asian, African American, or non-Hispanic White. 2. Scheduled to undergo a planned cesarean delivery. 3. Be of 18-45 years of age 4. Have a singleton pregnancy 5. Score between 5 and 13 on the Edinburgh Postnatal Depression Scale (EPDS) 6. A history of depression 7. Have no chronic pain condition (e.g., fibromyalgia) 8. Own a computer, smartphone, or tablet 9. Have a reliable internet access to complete the online surveys. 10. Be proficient in English or Spanish.
Meditation training to help reduce stress and reactivity to pain and other stressors.
Arctuva estimate
Verify or correct the compensation shown for this listing.